Clinical trial
Identification and Quantitation of Human B Regulatory Cells Via Flow Cytometry and Their Potential Role as a Treatment Efficacy Biomarker in Allergen-specific Immunotherapy
NCT06876506 is registered in ClinicalTrials.gov with Hull University Teaching Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification and Quantitation of Human B Regulatory Cells Via Flow Cytometry and Their Potential Role as a Treatment Efficacy Biomarker in Allergen-specific Immunotherapy
- Lead sponsor
- Hull University Teaching Hospitals NHS Trust
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 21, 2026
- Completion date
- September 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pollen allergy, venom allergy